SIRT1 exerts anti-hypertensive effect via FOXO1 activation in the rostral ventrolateral medulla

Free Radic Biol Med. 2022 Aug 1:188:1-13. doi: 10.1016/j.freeradbiomed.2022.06.003. Epub 2022 Jun 7.

Abstract

The rostral ventrolateral medulla (RVLM) is a pivotal region in the central regulation of blood pressure (BP). It has been documented that silent information regulator 2 homolog 1 (SIRT1), a nicotinamide adenine dinucleotide (NAD+)-dependent multifunctional transcription regulatory factor, has many cardiovascular protective effects. However, the role and significance of SIRT1 in the central regulation of cardiovascular activity, especially in RVLM, remains unknown. Therefore, the aim of this study was to explore the role and underlying mechanism of SIRT1 in the central regulation of cardiovascular activity in hypertension. Spontaneously hypertensive rats (SHRs) were given resveratrol (RSV) via intracerebroventricular (ICV) infusion or injected with SIRT1-overexpressing lentiviral vectors into the RVLM. In vitro experiments, angiotensin II (Ang II)-induced rat pheochromocytoma cell line (PC12 cells) were transfected with forkhead box protein O1 (FOXO1) small interfering RNA (siRNA) before treatment with RSV. Our results showed that SIRT1 activation with RSV or overexpression in the RVLM significantly decreased BP and sympathetic outflow of SHRs. Furthermore, SIRT1 overexpression in the RVLM significantly decreased reactive oxygen species (ROS) production and facilitated the forkhead box protein O1 (FOXO1) activation, accompanied by upregulation of the ROS-detoxifying enzyme superoxide dismutases 1 (SOD1) in the RVLM of SHRs. In PC12 cells, it was found that Ang II could induce oxidative stress and downregulate the SIRT1-FOXO1-SOD1 signaling pathway, which indicated that the suppressed expression of SIRT1 in the RVLM of SHRs might relate to the elevated central Ang II level. Furthermore, the enhanced oxidative stress and decreased SIRT1-FOXO1-SOD1 axis induced by Ang II were restored by treatment with RSV. However, these favorable effects mediated by SIRT1 activation were blocked by FOXO1 knockdown. Based on these findings, we concluded that SIRT1 activation or overexpression in the RVLM exerts anti-hypertensive effect through reducing oxidative stress via SIRT1-FOXO1-SOD1 signaling pathway, which providing a new target for the prevention and intervention of hypertension.

Keywords: Hypertension; Oxidative stress; Rostral ventrolateral medulla; SIRT1; Sympathetic outflow.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Antihypertensive Agents* / pharmacology
  • Blood Pressure
  • Forkhead Box Protein O1 / genetics
  • Heart Rate
  • Hypertension* / metabolism
  • Nerve Tissue Proteins
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Reactive Oxygen Species / metabolism
  • Sirtuin 1 / genetics
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / pharmacology
  • Superoxide Dismutase-1

Substances

  • Antihypertensive Agents
  • Forkhead Box Protein O1
  • Nerve Tissue Proteins
  • Reactive Oxygen Species
  • Angiotensin II
  • Foxo1 protein, rat
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • Sirt1 protein, rat
  • Sirtuin 1